Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthri
about
Bisphosphonates for osteoarthritisClinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAITThe effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trialEvaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE systemOn the predictive utility of animal models of osteoarthritisWolff's law in action: a mechanism for early knee osteoarthritisRole of bone architecture and anatomy in osteoarthritisState-of-the-Art management of knee osteoarthritisBiomarkers for osteoarthritis: current position and steps towards further validationPrognostic biomarkers in osteoarthritisThe evolving role of biomarkers for osteoarthritisBiochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritisBisphosphonates therapy for osteoarthritis: a meta-analysis of randomized controlled trialsEfficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trialDisease-modifying osteoarthritis drugs: in vitro and in vivo data on the development of DMOADs under investigation.Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative.Magnetic resonance imaging-based three-dimensional bone shape of the knee predicts onset of knee osteoarthritis: data from the osteoarthritis initiativeThe effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial.Osteoarthritis disease progression model using six year follow-up data from the osteoarthritis initiative.The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation.Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis.Effects of risedronate on osteoarthritis of the knee.Relationship of bone mineral density to progression of knee osteoarthritis.Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasisFuture directions for the management of pain in osteoarthritisSubchondral bone trabecular integrity predicts and changes concurrently with radiographic and magnetic resonance imaging-determined knee osteoarthritis progression.Effect of risedronate in a minipig cartilage defect model with allograft.Osteoarthritis: a disease of the joint as an organ.Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits.Are bisphosphonates effective in the treatment of osteoarthritis pain? A meta-analysis and systematic review.Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review.Diagnosis of Osteoarthritis by Cartilage Surface Smoothness Quantified Automatically from Knee MRI.Osteoarthritis and bone mineral density: are strong bones bad for joints?Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis.Imaging of cartilage and bone: promises and pitfalls in clinical trials of osteoarthritis.Effect of alendronate on post-traumatic osteoarthritis induced by anterior cruciate ligament rupture in mice.Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament modelComparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits.
P2860
Q24202794-D921AC20-BF54-496A-BEC4-21A24ACB2B85Q24602794-8DB303F3-A655-4060-889A-D84F81F4E0D6Q24630475-43B29FB7-647D-4E85-A940-F8AE69118534Q24647595-F17C7EF4-90F3-4257-8738-CE37DBD65DB6Q26781301-ACFECD36-AECF-4FF3-9089-AF7BCE0693F1Q26795665-3CD08CFD-9666-4E63-ACCE-E9277830E40FQ26829806-910222B9-BB34-45E4-B226-26BD2C341833Q26859086-A5F9478A-6B3C-4C66-BFCD-9901CE68C6CFQ27002552-45CBEA21-0901-4845-9DC3-2B2D358DC807Q27022211-7FFF7453-36A1-44D2-8710-3B92CA5F7088Q27025115-99E44BB1-AA74-43C2-B7E7-C487969A07E1Q27687777-5D6795C2-C3B8-46D7-9A69-BABD42C6ACCBQ28070177-DC43D2AB-116B-43E7-BAA7-F821E95D7DF3Q28076532-ECCC1830-4651-4BD0-8426-BCD3C9A7523BQ28278433-7FA483C4-B5E0-4DBF-9802-D3A728EEE0ECQ30588700-299953CF-2FB8-492E-A7F5-FCDF8D719F3AQ30616581-F6E53B34-7D28-4CA4-8481-032D25DC0A51Q30621600-D7D62AF0-F15F-4188-89EC-9ED44B381D7CQ30817745-11ABE049-1A20-4075-94D3-FBD16921B34FQ30850701-3EE8503E-34C1-444B-BAC0-9A5F703A1EAFQ33311301-E1675828-4332-48D3-A6C3-4507B910B11BQ33385519-09E4D009-8628-4016-B454-95C6408F6D66Q33622130-6FA6CDFA-C6EB-4FD2-ADD8-6F3A0AC2F096Q33670485-CFFD5085-3735-4123-909F-292CFBB935F3Q33699033-F5FB7972-B359-4411-A3BF-F29C4C4BB600Q33760068-3AC62BD6-0600-4594-BF42-A5D8BDBE0F70Q33874031-8257AB79-AAB8-4C7E-A759-E6B66027BDB2Q34122257-5EE6801A-B00A-4910-815D-EB1BE326F460Q34139901-CA533DBE-342D-4E69-A60B-3AB6E24DB475Q34258870-59E76662-E16C-45A9-B2BE-729D33EB4382Q34558569-A5ADE2A0-9C37-4D1B-812D-BE39F981CCB8Q34984018-CBEBB246-208B-4EC5-B6FB-4E9C2E9C6C07Q34984813-B5D80FCC-4DF1-4109-9425-9106ADCDC3E6Q34991538-EC776A94-3BCB-48E7-8C69-B0935875A9CDQ35000946-230C2308-2BD2-4CC7-901D-B2EB555F3D70Q35083065-F96B63D5-1E52-4803-88FD-AD346FA54B26Q35154096-CCBA3C4B-6206-44EF-B61D-971B2EC3DA04Q35164621-BDB80A34-931B-471D-953B-5DF27C301D59Q35557938-CA4CA778-5A26-4B06-BAC8-4BB094682D3EQ35634428-362C525D-066C-49B1-B1AD-B32BFF57594E
P2860
Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthri
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Risedronate decreases biochemi ...... multinational knee osteoarthri
@en
Risedronate decreases biochemi ...... multinational knee osteoarthri
@nl
type
label
Risedronate decreases biochemi ...... multinational knee osteoarthri
@en
Risedronate decreases biochemi ...... multinational knee osteoarthri
@nl
prefLabel
Risedronate decreases biochemi ...... multinational knee osteoarthri
@en
Risedronate decreases biochemi ...... multinational knee osteoarthri
@nl
P2093
P2860
P50
P921
P356
P1476
Risedronate decreases biochemi ...... multinational knee osteoarthri
@en
P2093
Clifton O Bingham
Gary A Cline
J Chris Buckland-Wright
Jean-Pierre Raynauld
Joan M Meyer
John F Beary
Lee S Simon
Patrick Garnero
Silvano Adami
Stanley B Cohen
P2860
P304
P356
10.1002/ART.22160
P577
2006-11-01T00:00:00Z